We are a world-leading cancer research institute dedicated to improving patient lives through discovery science. Using artificial intelligence to enhance cancer research and treatments. …

Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), formerly CRT Discovery Laboratories, is the in-house CRUK drug discovery unit with a principal focus on establishing …

Our world-class basic research drives and facilitates the development of translational and clinical research, leading to practice-changing developments for cancer patients.

The Cancer Molecular Diagnostics Laboratory (CMDL) is part of the University of Cambridge School of Clinical Medicine Dept. of Oncology, located on the Cambridge Biomedical Campus. …

The CRUK Scotland Institute (formerly the CRUK Beatson Institute)* is core-funded by Cancer Research UK and provides a dynamic, supportive and well-resourced environment for its basic …

Research in the CRUK Cambridge Institute focuses primarily on tumour ecology and evolution, with investigations across four main areas: Basic research into the cellular and molecular …

Our lab integrates machine learning and high-throughput biochemistry to study how proteins selectively recognize their substrates, how this process is perturbed in cancer and how it can …

Blood plasma of cancer patients contains DNA fragments that originate from the tumour. We leverage advanced genomic technologies to extract information from these fragments, using …

We award Centre status to locations performing the highest quality cancer research, providing over £100million of infrastructure investment funding for technical staff, equipment, training …

This unique interdisciplinary and collaborative network will generate novel innovative biological therapies, diagnostics and stratification strategies in addition to providing a clinical and …